本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.06
-0.0600-5.36%
成交量:538.68萬
成交額:569.85萬
市值:2.32億
市盈率:-0.87
高:1.12
開:1.12
低:1.02
收:1.12
資料載入中...
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/04

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/20

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/16

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/16

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/15

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/19

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/05

重要事件披露

8-K - Current report
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]